Medicine for treating cor pulmonale and its preparation method

A cor pulmonale and drug technology, applied in drug combination, pharmaceutical formula, cardiovascular system diseases, etc., can solve the problems of high mortality, high recurrence rate, unsatisfactory effect, etc., and achieve safe and effective clinical application, cough The effect of reducing the number of times and reducing the number of acute attacks

Inactive Publication Date: 2003-09-17
李湛明 +1
View PDF0 Cites 8 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there is no specific medicine for the treatment of cor pulmonale. Most of them are treated with anti-inflammatory, cough, asthma or heart disease drugs. The effect is not ideal, the recurrence rate is high, and the mortality rate is high.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0040] The medicine for treating cor pulmonale has the following components and weight: Astragalus 720g, Radix Paeoniae Rubra 720g, Psoraleae 360g.

[0041] For the above three flavors, grind 180g of red peony herb into fine powder; add water to decoct the remaining medicine twice, each time for 1 hour, combine the decoction, and filter; when the filtrate is concentrated to 80°C, the relative density is 1.05-1.15, add ethanol to The alcohol content reaches 60%, let it stand for 24 hours, filter the alcohol liquid, recover the ethanol until there is no alcohol smell, continue to concentrate to a thick paste with a relative density of 1.35-1.40 at 80°C, add red peony powder, stir evenly, dry, and pulverize , granulated, and dried into capsules to obtain 1000 capsules.

[0042] The present invention can also be made into tablet, granule, oral liquid and the like.

Embodiment 2

[0044] The medicine for treating cor pulmonale has the following components and weight: Astragalus 756g, Radix Paeoniae Rubra 684g, and Psoraleae 360g.

Embodiment 3

[0046] Medicine for treating cor pulmonale: its components and weight are: Astragalus 684g, Radix Paeoniae Rubra 756g, Psoraleae 430g.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

A Chinese medicine in the form of capsule, stable, particle, or oral liquid for treating pulmonary heart disease is prepared from 3 Chinese medicinal materials including astragalus root, red peony root and psoralea fruit through decocting twice (each time for 1 hr.), filtering, concentrating up to relative density of 1.05-1.15 at 80 deg.C, depositing in alcohol standing still for 24 hr, recovering alcohol, continuously concentrating up to relative density of 1.35-1.40 at 80 deg.C concentrating, mixing with red peony root powder, stirring, drying, pulverizing and granulating.

Description

technical field [0001] The invention relates to a medicine for treating cor pulmonale in remission stage, specifically a Chinese patent medicine made from traditional Chinese medicine, and also relates to a preparation method of the medicine. Background technique [0002] Pulmonary heart disease, also known as cor pulmonale, is the final stage of the development of chronic bronchitis, bronchial asthma, or other lung diseases, mainly caused by pulmonary hypertension caused by chronic bronchitis in primary lesions of lung tissue or pulmonary artery and its branches. resulting in heart disease. The incidence rate of cor pulmonale is relatively high in our country, which seriously endangers the health of human body. At present, there is no specific drug for the treatment of cor pulmonale, and most of them are treated with anti-inflammatory, cough, asthma or heart disease drugs. Contents of the invention [0003] The purpose of the present invention is in order to overcome th...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61P9/10
Inventor 李湛明关泽明
Owner 李湛明
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products